Company Profile
ClearPoint Neuro Stock Price, News & Analysis
- Ticker:
- CLPT
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, ClearPoint Neuro is followed within the biotech universe for its exposure to catalyst-driven execution.
Stock performance
18.53 USD (+8.62%)
Close
Last updated: June 23, 2026 at 00:00
555.71M USD
Market cap
Why the stock is moving
CLPT is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
ClearPoint Neuro is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, ClearPoint Neuro is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
ClearPoint Neuro follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, ClearPoint Neuro sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
- 02
- 03
ClearPoint Neuro Reports First Quarter 2026 Results
Source: ClearPoint Neuro
- 04
ClearPoint Neuro Announces Agreement to Acquire IRRAS
Source: ClearPoint Neuro
- 05
ClearPoint Neuro Reports Third Quarter 2025 Results
Source: ClearPoint Neuro
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of ClearPoint Neuro (CLPT)?
ClearPoint Neuro (CLPT) most recently closed at 18.53 USD, a +8.62% move versus the previous session.
What is the market cap of ClearPoint Neuro (CLPT)?
ClearPoint Neuro currently has a market capitalization of 555.71M USD on BioPharmSignal.
What does ClearPoint Neuro do?
ClearPoint Neuro is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is CLPT stock listed?
ClearPoint Neuro (CLPT) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, ClearPoint Neuro is followed within the biotech universe for its exposure to catalyst-driven execution., Biotechnology.
What is ClearPoint?
ClearPoint Neuro is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
Which conditions is ClearPoint Neuro targeting with ClearPoint?
ClearPoint Neuro is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
What is Neuro?
ClearPoint Neuro is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.